Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone

Plus, news about Adaptimmune, Roche, LIfT BioSciences, VerImmune, and Revance Therapeutics:

Capricor Therapeutics to file Duchenne cardiomyopathy treatment with the FDA: The San Diego-based biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Gilead, Tentarix partner on cancer and inflammation therapies

The partnerships aim to develop multifunctional, conditional protein therapeutics for oncology and inflammatory diseases. Credit: Kateryna Kon/Shutterstock.com. Gilead Sciences has entered into three multi-year partnerships

August 16, 2023

Boston Scientific gets FDA nod for latest device in fast-growing Watchman franchise

Dive Brief: Boston Scientific has gained approval for an updated version of its Watchman left atrial appendage closure (LAAC) device in the U.S. The U.S.

September 7, 2023

Lawmakers call for ‘line in the sand’ between US and Chinese biotech companies

Democrats and Republicans on the House Select Committee on the Chinese Communist Party railed against Chinese biotech companies in a Thursday hearing on national security,

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.